Literature DB >> 31247626

In vitro Post-Antifungal Effect of Posaconazole and Its Impact on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.

Arjuna Nishantha Bandara Ellepola1, Ranil Samantha Dassanayake2, Ziauddin Khan3.   

Abstract

OBJECTIVE: Candidal adherence to denture acrylic surfaces (DAS) and oral buccal epithelial cells (BEC), formation of candidal germ tubes (GT), candidal cell surface hydrophobicity (CSH), and hemolysin production are important pathogenic traits of Candida. The antifungal drug-induced post-antifungal effect (PAFE) also impacts the virulence of Candida. Candida dubliniensis isolates are associated with the causation of oral candidiasis which could be managed with posaconazole. Thus far there is no evidence on posaconazole-induced PAFE and its impact on adhesion-related attributes and production of hemolysin by C. dubliniensis isolates. Hence, the PAFE, adhesion to DAS and BEC, formation of GT, CSH, and hemolysin production of 20 oral C. dubliniensis isolates after brief exposure to posaconazole was ascertained.
MATERIALS AND METHODS: The PAFE, adherence to DAS and BEC, formation of GT, candidal CSH, and hemolysin production were investigated by hitherto described in vitro assays.
RESULTS: The mean PAFE (h) induced by posaconazole on C. dubliniensis isolates was 1.66. Exposure to posaconazole suppressed the ability of C. dubliniensis to adhere to DAS, BEC, formation of candidal GT, candidal CSH and to produce hemolysin by a reduction of 44, 33, 34, 36, and 15% (p < 0.005 to p < 0.001), respectively.
CONCLUSION: Exposure of C. dubliniensis isolates to posaconazole for a brief period induced an antimycotic impact by subduing its growth in addition to suppressing pathogenic adherence-associated attributes, as well as production of hemolysin.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Adhesion; Candida dubliniensis; Hemolysin; Posaconazole; Post-antifungal effect

Mesh:

Substances:

Year:  2019        PMID: 31247626      PMCID: PMC6944866          DOI: 10.1159/000501764

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  30 in total

1.  Assessment of Candida species colonization and denture-related stomatitis in complete denture wearers.

Authors:  Kamiar Zomorodian; Neda Nejabat Haghighi; Naeem Rajaee; Keyvan Pakshir; Bita Tarazooie; Mahroo Vojdani; Farzaneh Sedaghat; Mehrdad Vosoghi
Journal:  Med Mycol       Date:  2010-08-26       Impact factor: 4.076

2.  Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.

Authors:  Asmaa Al Mosaid; Derek J Sullivan; Itzhack Polacheck; Faisal A Shaheen; Osama Soliman; Saleh Al Hedaithy; Sahar Al Thawad; Motaz Kabadaya; David C Coleman
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Candida species exhibit differential in vitro hemolytic activities.

Authors:  G Luo; L P Samaranayake; J Y Yau
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 4.  A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.

Authors:  H Hof
Journal:  Mycoses       Date:  2006       Impact factor: 4.377

5.  Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.

Authors:  M Fleischhacker; J Pasligh; G Moran; M Ruhnke
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

Review 6.  Posaconazole: a broad-spectrum triazole antifungal.

Authors:  Harrys A Torres; Ray Y Hachem; Roy F Chemaly; Dimitrios P Kontoyiannis; Issam I Raad
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

7.  Production of a hemolytic factor by Candida albicans.

Authors:  J M Manns; D M Mosser; H R Buckley
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

Review 8.  Sensing the host environment: recognition of hemoglobin by the pathogenic yeast Candida albicans.

Authors:  Michael L Pendrak; S Steve Yan; David D Roberts
Journal:  Arch Biochem Biophys       Date:  2004-06-15       Impact factor: 4.013

9.  Candida dubliniensis fungemia: the first four cases in North America.

Authors:  M E Brandt; L H Harrison; M Pass; A N Sofair; S Huie; R K Li; C J Morrison; D W Warnock; R A Hajjeh
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883

10.  Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.

Authors:  Arjuna Nishantha Ellepola; Rana Khajah; Sumedha Jayatilake; Lakshman Samaranayake; Prem Sharma; Zia Khan
Journal:  J Appl Oral Sci       Date:  2015 Jul-Aug       Impact factor: 2.698

View more
  1 in total

Review 1.  Postantifungal Effect of Antifungal Drugs against Candida: What Do We Know and How Can We Apply This Knowledge in the Clinical Setting?

Authors:  Nerea Jauregizar; Guillermo Quindós; Sandra Gil-Alonso; Elena Suárez; Elena Sevillano; Elena Eraso
Journal:  J Fungi (Basel)       Date:  2022-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.